SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
KTTA

Pasithea Therapeutics Corp. (KTTA)

NASDAQ: KTTA · Real-Time Price · USD
Healthcare · Biotechnology
$0.51+$0.08 (+17.57%)
 
Market cap
$18.8M
Insider Score
Analyst consensus

KTTA analyst forecast

No analyst ratings in the last 12 months

No independent sell-side analyst publishes on KTTA that our data provider carries. That is normal for smaller listings, and it is not a judgement on the company. Here is what we track instead:

Best analysts covering KTTA

No firm covering KTTA has a call old enough to have finished a 1Y holding period yet.

Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.